Overjet vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
#1 dental AI platform for providers and payers. Founded 2018 at MIT/Harvard. $159M+ total funding, $550M valuation. Acquired DentalBee (2025). Private.
About
Overjet is the leading dental AI platform, founded in 2018 by computer scientists from MIT and dentists from Harvard, headquartered in Boston, Massachusetts. The company's FDA-cleared AI software analyzes dental X-rays in real time, helping providers detect conditions like bone loss and cavities with greater accuracy, and enabling insurance payers to automate claims review.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.